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Cholera toxin (CT) and islet-activating protein (IAP, a Boraktella pertussis toxin) were employed to test 
the hypothesis that GTP-binding regulatory proteins are released from plasma membranes to a greater ex- 
tent when ‘activated’ than when ‘inactivated’. CT, which activates N, (the stimulatory GTP-binding regula- 
tory protein of the adenylate cyclase system), catalyzed the incorporation of radioactivity from [32P]NAD 
into 45 and 47.5 kDa peptides associated with rat liver plasma membranes. Following ADP-ribosylation 
and centrifugation at 100000 x g for 1 h, approx. 30-35s of these CT-labelled peptides were no longer 
associated with the plasma membranes, but were recovered from the supernatant fraction. IAP, which inac- 
tivates N, (the inhibitory GTP-binding regulatory protein of the adenylate cyclase system) catalyzed the in- 
corporation of radioactivity from [QP]NAD into a 41 kDa peptide associated with the membranes. Howev- 
er, in contrast to the CT-labelled peptides, typically less than 5% of the IAP-labelled peptide was found 
in the 100000 x g supernatant fraction, but rather was almost exclusively associated with the membrane 
pellet. The data indicate that the a-subunits of N, are released from the plasma membrane following activa- 
tion, and support the hypothesis that the &-subunits act to anchor the a-subunits to the plasma membrane. 
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1. INTRODUCTION 
Rodbell and co-workers [l-3] have provided 
some preliminary evidence for a theory which pro- 
poses that, as a consequence of hormone stimula- 
tion or exposure to agents which activate GTP- 
binding proteins (e.g. fluoride, Mg, GTP, etc.), 
the a-subunits of these proteins are released from 
the plasma membrane. It is further proposed that 
the released u-subunits may then be free to interact 
with other components of the cell and/or plasma 
membrane. Thus the ,8- and/or y-subunits of these 
proteins would behave as moorings for attachment 
of the a-subunits to the plasma membrane. Recent 
evidence from Sternweis [4] showing that (Y- 
subunits of GTP-binding regulatory proteins can- 
not associate with plasma membranes in the 
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absence of &-subunits, would seem to support 
Rodbell’s hypothesis. 
In this study, cholera toxin (CT) and islet- 
activating protein (IAP) were employed to label 
and activate or inactivate, respectively, N, and Ni 
in purified rat liver plasma membranes. It is shown 
that as a consequence of the action of CT, two 
[32P]ADP-ribosylated peptides are released from 
the plasma membrane and these released peptides 
represent approx. 30-3970 of the total 45 and 
47.5 kDa labelling. In contrast, less than 5% of the 
41 kDa peptides [32P]ADP ribosylated by IAP 
were released from the plasma membrane. These 
data support the theory that release of cu-subunits 
from plasma membranes may be a consequence of 
the activation of a GTP-binding regulatory 
protein. 
2. MATERIALS AND METHODS 
[32P]NAD was obtained from New England 
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Nuclear (Boston, MA). IAP was purchased from 
List Biological Laboratories (Campbell, CA) and 
was activated as described [5]. CT A subunit was 
obtained from either List Biological Laboratories 
or Calbiochem (La Jolla, CA). M, standards were 
purchased from BioRad (Richmond, CA). Sources 
of other materials have been described [5,6]. 
Plasma membranes isolated from a rat liver by 
density gradient centrifugation [6] using Percoll 
(Pharmacia Fine Chemicals, Piscataway, NJ) were 
divided equally into two centrifuge tubes and 
washed in ice-cold isolation media containing 
isotonic sucrose, 5 mM Na-Hepes (pH 7.4), 1 mM 
EGTA and 20 pg/ml each of leupeptin and anti- 
pain. One pellet (approx. 5-6 mg of protein) was 
then resuspended in 1.5 ml of IAP-ribosylating 
buffer containing 1 mM EDTA (pH 7.4), 10 mM 
thymidine and protease inhibitors (20 pg/ml each 
of leupeptin and antipain), while the other pellet 
was resuspended in CT-ribosylating buffer con- 
taining 400 mM potassium phosphate (pH 7.4), 
10 mM MgClz, 1 mM EGTA, 10 mM thymidine 
and protease inhibitors as above. Conditions for 
toxin-catalyzed ADP-ribosylation were in- 
dividualized for each toxin to optimize labelling as 
recommended by Riberio-Neto et al. [7]. The IAP- 
stimulated [32P]ADP-ribosylation assay mixture 
contained final concentrations of the following in 
500 #ul: 10 mM [32P]NAD (50-60 &i/tube), 
50 mM Na-Hepes (pH 7.4), 10 mM thymidine, 
1 mM EDTA, 1 mM ATP, 0.1 mM GTP, 
50pg/ml of activated IAP, 400~1 of membranes 
in IAP-ribosylating buffer (see above) and pro- 
tease inhibitors as above. The CT [32P]ADP- 
ribosylation assay mixture contained final concen- 
trations of the following in 500~1: 10 mM 
[32P]NAD (50-60 &i/tube), 50 mM Na-Hepes 
(pH 7.4), 400 mM potassium phosphate (pH 7.4), 
10 mM MgClz, 10 mM thymidine, 1 mM EGTA, 
1 mM ATP, 0.1 mM GTP, 50 or lOOpg/ml of CT 
A subunit, 400~1 of membranes in CT- 
ribosylating buffer (see above) and protease in- 
hibitors as above. Both assays were carried out at 
30°C and were started with the addition of 
[32P]NAD, ATP and GTP. Additional [32P]NAD, 
ATP and GTP were added at 7 min intervals for 
27 min. 
Following this period, the mixtures were dif- 
ferentially adjusted as necessary to yield final con- 
centrations of the following in 1 ml: 25 mM Na- 
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Hepes (pH 7.4), 200 mM potassium phosphate 
(pH 7.4), 10 mM MgClz, 1 mM EDTA, 1 mM 
EGTA, 10 mM thymidine, 20 pg/ml each of 
leupeptin and antipain. After an additional 10 min 
with shaking at 3O”C, 50~1 fractions (for deter- 
mination of total labelling) of each tube were 
precipitated in an Eppendorf tube containing 1 ml 
of 15% trichloroacetic acid, 45% EtOH. A volume 
(400 #l) of the remainder was transferred to a cen- 
trifuge tube and centrifuged for 1 h at 100000 x g 
(4°C) in a Beckman airfuge fitted with an A-95 
rotor. 50 ~1 of each supernatant was then 
precipitated with trichloroacetic acid as described 
above for determination of soluble labelled pro- 
teins, and the remaining supernatant was carefully 
discarded. The 100000 x g pellets were resuspend- 
ed in a 400 pl final volume of isolation media and 
50 ~1 of this mixture was also precipitated with 
trichloroacetic acid for the determination of mem- 
brane associated ADP-ribosylated proteins. 
Precipitated proteins were sedimented at 
11000 x g for 5 min and the supernatant was 
removed. The protein was then solubilized by boil- 
ing in 300~1 of 12% SDS, 25% glycerol, 25 mM 
DTT, 20 mM Tris, 0.15 M glycine buffer (pH 8.2) 
and 0.03% bromophenol prior to SDS-PAGE of 
50 or 100 ~1 of each sample in duplicate. Mr stan- 
dards were labelled for autoradiography with 
EMIT (New England Nuclear) following 
Coomassie blue staining. Autoradiographs were 
prepared from the dried gels by overnight exposure 
(-70°C) of Kodak XAR-5 film in cassettes with 
DuPont Quanta III enhancing screens. The 
radioactive contents of the 45-48 kDa (Nscu) and 
41 kDa (Na) regions of the gels were determined 
by slicing these Mr regions from wet gels into vials 
containing 10 ml Beckman Redisolv EP and 
counting in a Beckman LS 1800 liquid scintillation 
counter. The experiments hown are representative 
of three such studies. 
3. RESULTS 
Fig.1 shows that a number of major proteins 
isolated with liver plasma membranes are partly 
lost during centrifugation following exposure at 
30°C to constituents of the ADP-ribosylation 
assay mixtures. Neither CT-catalyzed ADP- 
ribosylation nor IAP-catalyzed ADP-ribosylation 
differentially affected the release of these major 
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Fig. 1. Coomassie blue-stained SDS-polyacrylamide gel 
showing the release of soluble proteins from isolated 
liver plasma membranes. IAP- (lanes l-6) and CT- 
(lanes 7-12) catalyzed [32P]ADP-ribosylation of isolated 
liver plasma membranes was performed under different 
conditions as described in section 2. Membranes were 
then incubated under similar conditions prior to 
centrifugation and SDS-PAGE of proteins from total 
membranes (lanes 1,2,7,8), 100000 x g supernatant 
fraction (lanes 3,4,9,10) and resuspended 100000 x g 
pellet (lanes 5,6,11,12). Lane S contains Coomassie blue- 
stained (EMIT-labelled) A4, standards. The peptides in 
the 21-31 kDa region of the gels which appear in lanes 
l-6 but not lanes 7-12 (and vice versa) are subunits of 
the toxins which are also precipitated by trichloroacetic 
acid. 
proteins as determined from Coomassie blue 
staining. 
CT catalyzed the incorporation of radioactivity 
from [32P]NAD into two peptides of approx. 45 
and 47.5 kDa. Following incubation in a medium 
containing a mixture of the CT and IAP-assay 
components and then centrifugation, approx. 
30-35070 of these two CT-labelled peptides were 
found in the 100000 x g supernatant (fig.2). In 
contrast, typically less than 5% of the 41 kDa pep- 
tide labelled in the presence of IAP was apparent 
in 100000 x g supernatant fraction. The figure on- 
ly shows the region of gels in the vicinity of the 
43 kDa ovalbumin marker protein, but, as shown 
in previous reports from our laboratory [5,8], the 
toxins do not significantly ADP-ribosylate other 
proteins in liver plasma membranes. 
4. DISCUSSION 
N, and Ni are part of a family of homologous 
Fig.2. Release of [32P]ADP-ribosylated proteins from 
liver plasma membranes. Two portions of an 
autoradiograph obtained from the gel in fig.1 showing 
[32P]ADP-labelling of peptides by IAP (lanes l-6) and 
CT (lanes 7-12). OVA, position of ovalbumin relative to 
the labelled peptides. 
GTP-binding regulatory proteins that act as signal 
transducers and amplifiers in the adenylate cyclase 
system. These two proteins are thought to be 
heterotrimeric, consisting of cr-, ,& and y-subunits 
(review see [9]). The fly-subunits for each protein 
are thought to be very similar or identical, while 
the a-subunits differ in Mr and in activity in the 
adenylate cyclase system. While the specific activi- 
ty of these proteins is typically enriched in plasma 
membrane fractions, three studies have emerged 
which suggest hat the a-subunits of these proteins 
may not be strictly limited to this structure 
[ 1 ,lO-121. For instance, Pecker and Hanoune [lo] 
demonstrated that a nucleotide-containing 
protease-sensitive factor is present in rat liver 
cytosol fractions which enhances GTP regulation 
of epinephrine-sensitive adenylate cyclase activity 
(this is presumed to be, but not positively iden- 
tified as, the a-subunit of N,). Similarly Bhat and 
co-workers [ 1 I] have isolated supernatant frac- 
tions from a number of tissues which confer 
guanine nucleotide and fluoride sensitivity on the 
adenylate cyclase of cyc- mutants of S49 murine 
lymphoma cells. Nakamura and Ui [12] reported 
the predominant occurrence of the a-subunit of Ni 
(or a similar IAP-sensitive protein) in the cytosol 
fraction of mast cells. 
Neilsen et al. [l] have shown that when plasma 
membranes from cyc- mutants of S49 cells are in- 
cubated with plasma membranes from other 
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sources which contain N,, in the presence of fac- 
tors’which activate N, (e.g. F-, Mg’+, GTP and 
ADP-ribosylation by CT), the adenylate cyclase 
activity of the cyc- membranes increases. Rodbell 
[2,3] has put forward a mechanistic hypothesis 
from these and other data which depicts the c~- 
subunits of GTP-binding regulatory proteins as 
‘programmable messengers’ which are released 
from the plasma membrane when exposed to ac- 
tivating agents (such as hormones, F, Mg and GTP 
analogs). Interestingly, the data of Sternweis [4] 
suggest that &subunits of GTP-binding 
regulatory proteins may indeed act to anchor a- 
subunits to the plasma membranes. 
In this study we have tested the hypothesis that 
inactivation of a GTP-binding protein may prevent 
its dissociation from the plasma membrane, while 
activation may promote its release. N, was ac- 
tivated by incubation of membranes with 
[32P]NAD and CT, while Ni was inactivated by in- 
cubation with [32P]NAD and IAP. [32P]ADP- 
ribosylation by CT resulted in the labelling of 45 
and 47.5 kDa peptides (which are presumably 
associated with the activation of the adenylate 
cyclase system), whereas IAP [32P]ADP- 
ribosylated a single 41 kDa peptide (presumably 
the a-subunit of Ni) (see [5] for references). 
Following incubation in a common medium and 
centrifugation at 100000 x g, a number of major 
proteins were found in the supernatant fractions as 
detected by Coomassie blue staining (fig.1). The 
toxins appeared to have no differential effect on 
the release of these major proteins from liver mem- 
branes. However, the toxins did appear to have a 
differential effect on the release of [32P]ADP- 
ribosylated peptides. Fig.2 shows that a significant 
percentage of the two peptides labelled by 
[32P]NAD and CT was no longer associated with 
the plasma membrane following centrifugation, 
while the 41 kDa peptide labelled by IAP remained 
almost exclusively associated with plasma mem- 
brane. While further studies will be required to 
determine whether hormones such as glucagon and 
angiotensin II promote the release of N, and Ni, 
respectively, from plasma membranes, the present 
data lend support to the programmable messenger 
hypothesis. 
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